Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Noteable....if you had to guess?

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Aug 19, 2021 12:26pm

137 Views

Post# 33730807

RE:RE:RE:RE:Noteable....if you had to guess?

It appears that by being outed here on Stockhouse, the multiple ID poster "dreamer" has deleted his post on Yahoo in reply to Harry, that I "copied and pasted" for this message board to see. 'dreamer's" post is confirmed as existing, even though he now removed it, through the subsequent response by "Anonymous' who refers to 'dreamer's' post. That being said "Anonymous" has posted in accordance with "following the leader's" [aka armedescapade's] orders, in another attempt to drive up readers 'emotions', in their attempt try to exploit the trades.

3 hours ago

For every action there is an equal and opposite reaction. I was fooled into buying and holding by pumpers many years ago... I've since learned to trust my instincts and have made up my losses.

There are some who come here, and as Dreamer states, just copy/paste articles that may or may not have direct relevance to ONCY.

Stating how much profits Pfizer makes in a quarter and then stating they are looking to acquire businesses that fit their portfolio... well, duh... Of course they're on the lookout.

ONCY management has trumpeted a partnership on conference calls for over 8 years. The data (IND-213) they present are from a trial started in 2012. And they've had final data for over 4 years.

Matt stated that AWARE-1 would take a few months, it began in April 2019 - 8 months before Covid. And it is still incomplete, and I wouldn't expect final data by year end either. Matt also stated this was all that big pharma needed to pull the trigger on a deal... BS

Suddenly that became, oh, now they need to repeat IND-213 but include a CPI also.

Though the pumpers will keep stating the minutiae of the science underpinning the theoretical mode of action, ONCY does not yet have data that proves the addition of CPI enhances overall survival. Until the Bracelet-1 data demonstrates this, this stock is an avalanche waiting to collapse.

IF the data is great... huzzah... we'll all be very happy... But it is certainly not a foregone conclusion. This whole debacle should be resolved by Q2 2022, assuming they have data by then. Every other trial ONCY has run has been years (yes years) late. So judge them on their past performance, and balance these risks when you read the positive, heart pounding posts that the pumpers are selling.